Inhaled drugs for COPD have been shown to relieve symptoms, improve quality of life and prevent or treat flare-ups. Treatment with these inhaled drugs tends to begin with one inhaler, and additional ...

COPD is a progressive disease where airway inflammation plays an important part. Previously, there were large expectations that regular anti-inflammatory treatment with inhaled corticosteroids (ICS) ...

Background Psychological functioning is an important determinant of health outcomes in chronic lung disease. To better define the role of anxiety in chronic obstructive pulmonary disease (COPD), a ...

Breztri can cost $400 or more without insurance, but Medicare may cover inhaler drugs for COPD, including Breztri. That said, the specific coverage and costs can vary depending on your exact plan.

If your COPD symptoms are not under control and you keep having flare-ups, you may benefit from a triple therapy inhaler.

Digital inhalers that measure and record inhalation data and that can remotely monitor patients may help predict impending chronic obstructive pulmonary disease (COPD) exacerbations, that is, episodes ...

Add the LAMA inhaler tiotropium and measure FEV 1 in a scheduled follow-up visit 2 weeks later. Tiotropium and a LABA have an additive effect on airway bronchodilatation.

With greater clinical severity, they recommend adding a long-acting muscarinic receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA) combination for 'triple therapy'.

DIGITAL inhaler metrics may offer an early signal of impending COPD exacerbations, according to a new pilot study evaluating real-world use of the ProAir Digihaler among high-risk patients.

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study.

MDIs, primarily as SABA or ICS, accounted for over half of inhalers dispensed to US older adults. Most insurance plans excluded sustainable alternatives for SABA/ICS. When covered, additional approval ...